ADVOCACY

The SDP Impact

Nilia had no family history of type 1 diabetes (T1D), but newborn screening, as part of a Special Diabetes Program (SDP) funded trial, found she is at risk for developing it.

All Stories

  • Nilia

    SDP Trial Participant

Nilia's Story

Nilia had no family history of type 1 diabetes (T1D), but newborn screening, as part of a Special Diabetes Program (SDP) funded trial, found she is at risk for developing it.  She is participating in the trial until age 15 or T1D onset to help determine if diet, illnesses, or other exposures during her childhood are environmental triggers of T1D onset.  This critically important research could enable scientists to prevent T1D altogether.  Helping others along the way – SDP-related research underway today will not only continue to help prevent or delay the onset of complications in more than 26 million Americans with diabetes, it could also improve the lives of people living with autoimmune and other diseases.